Enterprise Value
9.747M
Cash
748K
Avg Qtr Burn
-5.066M
Short % of Float
11.69%
Insider Ownership
19.17%
Institutional Own.
13.43%
Qtr Updated
06/30/23
Drug Pipeline
Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
Drug & Indication | Stage & Event | Catalyst Date |
---|---|---|
NurOwn (autologous MSC-NTF) Details Amyotrophic lateral sclerosis, Neurodegenerative disease | Phase 3 Update | |
NurOwn (autologous MSC-NTF) Details Multiple sclerosis | Failed Discontinued |